Skip to main content
CDC Website

Guidance for Hepatitis C Treatment Monitoring

This information sheet provides guidelines for clinicians’ use in monitoring patients with hepatitis C, who are being treated with peginterferon, ribavirin, and one of the protease inhibitors, either boceprevir or telaprevir. It includes a chart of the laboratory tests to be conducted at baseline and every two weeks to week 48 and six months post treatment as well as other tests to be done periodically while the patient is on antiviral therapy.
Audiences:
Physicians
Population:
Health Professionals
Focus Area:
Viral Hepatitis
Topics/Subjects:
Testing and Counseling
Treatment and Care
Subjects:
Medical Treatments and Therapies
Patient Care
Persons with Hepatitis
Veterans
Publication Date:
2012
Format:
Information Sheet
2p.: col.; table.
Last Updated Date:
Publication ID:
35146